Literature DB >> 23360462

Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States.

Katherine Mercy1, Mary Kwasny, Kelly M Cordoro, Alan Menter, Wynnis L Tom, Neil Korman, Leah Belazarian, April W Armstrong, Moise L Levy, Amy S Paller.   

Abstract

The clinical features of pediatric psoriasis warrant further attention. A national study was conducted to determine the prevalence of scalp and nail involvement and a history of guttate psoriasis at onset according to age, sex, and disease severity. One hundred eighty-one children ages 5 to 17 years with plaque psoriasis were enrolled in a multicenter, cross-sectional study. Subjects and guardians were asked about a history of scalp and nail involvement and whether the initial presentation was guttate. Peak psoriasis severity was assessed and defined historically as mild psoriasis (MP) or severe psoriasis (SP) according to the Physician's Global Assessment and body surface area measures. One hundred forty-three (79.0%) subjects reported a history of scalp involvement, and 71 (39.2%) described a history of nail involvement. Boys were less likely than girls to report a history of scalp involvement (odds ratio [OR] = 0.40, 95% confidence interval [CI] = 0.19-0.84) but more likely to have had nail involvement (OR = 3.01, 95% CI = 1.62-5.60). Scalp and nail involvement was not related to psoriasis severity. In contrast, subjects with SP (35.9%) more often reported a history of guttate lesions than did those with MP (21.8%) (p = .02). Antecedent streptococcal infection was more common in children with guttate than those with plaque psoriasis at onset (p = .02) but did not correlate with severity. Sex-related differences in scalp and nail involvement suggest koebnerization. Preceding streptococcal infection predicts guttate morphology but not severity, and initial guttate morphology is associated with eventual greater severity of disease. More aggressive monitoring and management should be considered for guttate psoriasis, given its later association with more severe disease.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23360462      PMCID: PMC3641153          DOI: 10.1111/pde.12072

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  21 in total

1.  Psoriasis in children. A short review and a survey of 245 cases.

Authors:  A Nyfors; K Lemholt
Journal:  Br J Dermatol       Date:  1975-04       Impact factor: 9.302

2.  Childhood psoriasis: a clinical review of 1262 cases.

Authors:  A Morris; M Rogers; G Fischer; K Williams
Journal:  Pediatr Dermatol       Date:  2001 May-Jun       Impact factor: 1.588

3.  How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?

Authors:  B A Martin; R J Chalmers; N R Telfer
Journal:  Arch Dermatol       Date:  1996-06

4.  The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study.

Authors:  A L Tan; M Benjamin; H Toumi; A J Grainger; S F Tanner; P Emery; D McGonagle
Journal:  Rheumatology (Oxford)       Date:  2006-07-11       Impact factor: 7.580

5.  Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases.

Authors:  Lotus Mallbris; Per Larsson; Susanne Bergqvist; Eva Vingård; Fredrik Granath; Mona Ståhle
Journal:  J Invest Dermatol       Date:  2005-03       Impact factor: 8.551

6.  Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience.

Authors:  V Brazzelli; A Carugno; A Alborghetti; V Grasso; R Cananzi; L Fornara; A De Silvestri; G Borroni
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-10-06       Impact factor: 6.166

7.  National Psoriasis Foundation clinical consensus on disease severity.

Authors:  David M Pariser; Jerry Bagel; Joel M Gelfand; Neil J Korman; Christopher T Ritchlin; Bruce E Strober; Abby S Van Voorhees; Melodie Young; Sheila Rittenberg; Mark G Lebwohl; Elizabeth J Horn
Journal:  Arch Dermatol       Date:  2007-02

8.  Psoriasis in childhood and adolescence: evaluation of demographic and clinical features.

Authors:  Muammer Seyhan; Başak Kandi Coşkun; Hülya Sağlam; Hamdi Ozcan; Yelda Karincaoğlu
Journal:  Pediatr Int       Date:  2006-12       Impact factor: 1.524

9.  Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.

Authors:  Richard G Langley; Charles N Ellis
Journal:  J Am Acad Dermatol       Date:  2004-10       Impact factor: 11.527

10.  Epidemiology of childhood psoriasis: a study of 419 patients from northern India.

Authors:  Bhushan Kumar; Rajesh Jain; Kamaldeep Sandhu; Inderjeet Kaur; Sanjeev Handa
Journal:  Int J Dermatol       Date:  2004-09       Impact factor: 2.736

View more
  13 in total

1.  Nail Psoriasis in Children: Common or Uncommon? Results from a 10-Year Double-Center Study.

Authors:  Bianca Maria Piraccini; Ioanna Triantafyllopoulou; Christos Prevezas; Michela Starace; Iria Neri; Annalisa Patrizi; Maurizio Caserini; Renata Palmieri; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2015-04-01

Review 2.  Adolescent Scalp Psoriasis: Update on Topical Combination Therapy.

Authors:  Emily Osier; Barbara Gomez; Lawrence F Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

3.  Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study.

Authors:  Daniel B Horton; Frank I Scott; Kevin Haynes; Mary E Putt; Carlos D Rose; James D Lewis; Brian L Strom
Journal:  JAMA Dermatol       Date:  2016-02       Impact factor: 10.282

4.  Skin-infiltrating, interleukin-22-producing T cells differentiate pediatric psoriasis from adult psoriasis.

Authors:  Kelly M Cordoro; Maria Hitraya-Low; Keyon Taravati; Priscila Munoz Sandoval; Esther Kim; Jeffrey Sugarman; Mariela L Pauli; Wilson Liao; Michael D Rosenblum
Journal:  J Am Acad Dermatol       Date:  2017-06-16       Impact factor: 15.487

5.  Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.

Authors:  Lawrence F Eichenfield; Cecilia Ganslandt; Merle Kurvits; Joel Schlessinger
Journal:  Pediatr Dermatol       Date:  2014-11-21       Impact factor: 1.588

Review 6.  Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.

Authors:  I M G J Bronckers; A S Paller; M J van Geel; P C M van de Kerkhof; M M B Seyger
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

7.  Treatment of nail psoriasis: common concepts and new trends.

Authors:  Yasemin Oram; A Deniz Akkaya
Journal:  Dermatol Res Pract       Date:  2013-05-13

8.  Antistreptococcal interventions for guttate and chronic plaque psoriasis.

Authors:  Gwendy Dupire; Catherine Droitcourt; Carolyn Hughes; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2019-03-05

9.  Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate-to-severe psoriasis: a post hoc analysis from IXORA-PEDS.

Authors:  M M B Seyger; A Reich; C El Baou; C Schuster; E Riedl; A S Paller
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-08-27       Impact factor: 9.228

Review 10.  Psoriasis in children.

Authors:  Roxanne Pinson; Bahman Sotoodian; Loretta Fiorillo
Journal:  Psoriasis (Auckl)       Date:  2016-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.